Published by Bianca Boorer on 10th January 2017
(ShareCast News) - Futura Medical, an AIM listed innovative healthcare company focused on transdermal technology, has signed a licensing agreement with Thornton & Ross for the commercialisation of TPR100, the company's novel diclofenac gel for pain relief.
URL: http://www.digitallook.com/dl/news/story/25415119/...